SEC Form 4 · accession 0001209191-17-054452
PORTOLA PHARMACEUTICALS INC · PTLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John T Curnutte
Officer — Executive Vice President
Period of report
Sep 28, 2017
Accepted (ET)
Sep 29, 2017 · 6:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001269021
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 28, 2017 | M | 6,715 | $8.50 | A | 6,715 | D | |
| Common Stock | Sep 28, 2017 | M | 14,285 | $7.00 | A | 14,285 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $8.50 | Sep 28, 2017 | M | 6,715 | D | Mar 23, 2011 | Mar 22, 2021 | Common Stock | 6,715 | 5,049 | D |
| Employee Stock Option (right to buy) | $7.00 | Sep 28, 2017 | M | 14,285 | D | Mar 8, 2012 | Mar 7, 2022 | Common Stock | 14,285 | 0 | D |